Characterization of two proline dipeptidases (prolidases) from the hyperthermophilic archaeon Pyrococcus horikoshii.

Appl Microbiol Biotechnol

Department of Microbiology, North Carolina State University, 4548 Gardner Hall, Campus Box 7615, Raleigh, NC 27695-7615, USA.

Published: March 2010

Prolidases hydrolyze the unique bond between X-Pro dipeptides and can also cleave the P-F and P-O bonds found in organophosphorus compounds, including the nerve agents, soman and sarin. The advantages of using hyperthermophilic enzymes in biodetoxification strategies are based on their enzyme stability and efficiency. Therefore, it is advantageous to examine new thermostable prolidases for potential use in biotechnological applications. Two thermostable prolidase homologs, PH1149 and PH0974, were identified in the genome of Pyrococcus horikoshii based on their sequences having conserved metal binding and catalytic amino acid residues that are present in other known prolidases, such as the previously characterized Pyrococcus furiosus prolidase. These P. horikoshii prolidases were expressed recombinantly in the Escherichia coli strain BL21 (lambdaDE3), and both were shown to function as proline dipeptidases. Biochemical characterization of these prolidases shows they have higher catalytic activities over a broader pH range, higher affinity for metal and are more stable compared to P. furiosus prolidase. This study has important implications for the potential use of these enzymes in biotechnological applications and provides further information on the functional traits of hyperthermophilic proteins, specifically metalloenzymes.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00253-009-2235-xDOI Listing

Publication Analysis

Top Keywords

proline dipeptidases
8
pyrococcus horikoshii
8
horikoshii prolidases
8
biotechnological applications
8
furiosus prolidase
8
prolidases
6
characterization proline
4
dipeptidases prolidases
4
prolidases hyperthermophilic
4
hyperthermophilic archaeon
4

Similar Publications

BMY 7378, a selective α-adrenoceptor antagonist, is a new angiotensin converting enzyme inhibitor: In silico, in vitro and in vivo approach.

Biochim Biophys Acta Gen Subj

January 2025

Unidad de Investigación en Biomedicina, Carrera de Enfermería, Facultad de Estudios Superiores-Iztacala, Universidad Nacional Autónoma de México, Av. de los Barrios 1, Los Reyes Iztacala, Tlalnepantla 54090, Estado de México, México. Electronic address:

BMY 7378 is a multitarget drug primarily known for its selective antagonism of α-adrenoceptors (α-AR), exhibiting both hypotensive effects and the ability to prevent or reverse angiotensin II-induced vascular hypertrophy. Notably, BMY 7378 contains a phenylpiperazine moiety, a structural feature associated with angiotensin-converting enzyme (ACE) inhibition. This study aimed to investigate ACE inhibition as a potential pharmacological mechanism of BMY 7378.

View Article and Find Full Text PDF

Identification of Structure-Linked Activity on Bioactive Peptides from Sea Cucumber (): A Compressive Study.

Front Biosci (Landmark Ed)

October 2024

Department of Seafood Science and Technology, The Institute of Marine Industry, Gyeongsang National University, 53064 Tongyeongsi, Gyeongsangnamdo, Republic of Korea.

Background: A sea cucumber () is an invertebrate rich in high-quality protein peptides that inhabits the coastal seas around East Asian countries. Such bioactive peptides can be utilized in targeted disease therapies and practical applications in the nutraceutical industry.

Methods: Bioactive peptides were isolated from through ultrafiltration and Sephadex G-10 size exclusion chromatography.

View Article and Find Full Text PDF

A rare cause of immune dysregulation, prolidase deficiency: a case report and review of the literature.

Immunol Res

December 2024

Division of Pediatric Genetics, Department of Child Health and Diseases, Faculty of Medicine Hospital, Dokuz Eylul University, Izmir, Turkey.

We report a pediatric patient with prolidase deficiency, caused by a mutation in the PEPD gene, which encodes the enzyme prolidase D, with a lupus-like clinic and marked dysmorphic features along with pulmonary, neurological, skeletal, and immune system involvement. In addition to being the first known case in the literature where Friedrich's ataxia and prolidase deficiency were observed together, we aimed to highlight that this diagnosis should be considered in patients with autoimmunity and additional systemic findings such as treatment-resistant skin lesions, intellectual disability, and pulmonary manifestations. Furthermore, we sought to compare this case with others documented in the literature.

View Article and Find Full Text PDF

Correlation of insertion/deletion gene polymorphism with captopril effectiveness in Indonesian hypertensive patients.

Pharmacogenomics

September 2024

Departement of Pharmacology & Clinical Pharmacy, Faculty of Pharmacy, Universitas Gadjah Mada, Yogyakarta, Indonesia.

Hypertension is a prevalent health concern in Indonesia, with a high percentage of patients unresponsive to ACE inhibitor treatment. This multicenter case-control study investigated the correlation between ACE I/D and captopril effectiveness in Indonesian hypertensive patients. Hypertensive patients were divided into control (n = 69) and case (n = 73) groups.

View Article and Find Full Text PDF
Article Synopsis
  • Isoleucine-proline-proline (IPP) is a natural tripeptide that inhibits angiotensin-converting enzyme (ACE), playing a role in reducing hypertension and sympathetic activity in a rat study.
  • The study involved male Sprague-Dawley rats with induced hypertension, showing that IPP injections into the brain and bloodstream effectively lowered both sympathetic nerve activity and blood pressure by mitigating ACE activity and oxidative stress.
  • Long-term treatment with IPP also led to significant reductions in hypertension and vascular changes, highlighting its potential as a therapeutic approach for managing high blood pressure.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!